Abstract: The invention relates to extracorporeal blood circuits, and components thereof (e.g., hollow fiber membranes, potted bundles, and blood tubing), including 0.005% to 10% (w/w) surface modifying macromolecule. The extracorporeal blood circuits have an antithrombogenic surface and can be used in hemofiltration, hemodialysis, hemodiafiltration, hemoconcentration, blood oxygenation, and related uses.
Type:
Grant
Filed:
April 19, 2016
Date of Patent:
June 27, 2017
Assignee:
Interface Biologies, Inc.
Inventors:
Sanjoy Mullick, Weilun Chang, Hanje Chen, Mark A. Steedman, Roseita Esfand